Evolution of the Average Target: Cardinal Health, Inc.

Evolution of the Average Target - Cardinal Health, Inc.

Evolution of the Target Price: Cardinal Health, Inc.

Evolution of the Target Price - Cardinal Health, Inc.

Changes in Analyst Recommendations: Cardinal Health, Inc.

ee67ca21d4740f7b79344d1d2abeb1.nV5-Icnki6AAlyVRAK1E1kqUozZ0Z8TvEU-7_619rAg.2gc9FvCv8fJC7xcwOZkgow_563MiC4KoQnmWkZQoyFfSbC558KDE8mLtTg~328bd2e185851b32e359cef4cbd120e3
11-09 TD Cowen Adjusts Price Target on Cardinal Health to $304 From $280 MT
11-06 UBS Adjusts Cardinal Health Price Target to $310 From $295, Maintains Buy Rating MT
11-06 Deutsche Bank Adjusts Cardinal Health Price Target to $265 From $261, Maintains Hold Rating MT
11-06 RBC Raises Price Target on Cardinal Health to $295 From $276, Keeps Outperform Rating MT
11-05 Evercore ISI Adjusts Cardinal Health Price Target to $320 From $270 MT
10-20 Mizuho Adjusts Price Target on Cardinal Health to $280 From $250 MT
10-16 UBS Adjusts Cardinal Health Price Target to $295 From $280, Maintains Buy Rating MT
10-13 Cardinal Health Could Benefit From RayzeBio's Phase 3 Success, RBC Says MT
10-12 Baird Adjusts Price Target on Cardinal Health to $276 From $274 MT
10-01 Evercore ISI Adjusts PT on Cardinal Health to $270 From $265, Maintains Outperform Rating MT
08-19 Cardinal Health's Integration of Higher-Margin Services Will Drive Outperformance, RBC Says MT
08-19 RBC Initiates Cardinal Health at Outperform With $276 Price Target MT
08-13 Evercore ISI Adjusts Cardinal Health PT to $270 From $265, Maintains Outperform Rating MT
08-13 TD Cowen Adjusts Cardinal Health Price Target to $280 From $275, Maintains Buy Rating MT
08-13 JPMorgan Adjusts Cardinal Health Price Target to $260 From $215, Maintains Neutral Rating MT
08-13 Deutsche Bank Adjusts Cardinal Health Price Target to $261 From $223, Maintains Hold Rating MT
08-12 Barclays Adjusts Cardinal Health Price Target to $275 From $258, Maintains Overweight Rating MT
08-12 Evercore ISI Adjusts PT on Cardinal Health to $265 From $270, Maintains Outperform Rating MT
08-12 UBS Adjusts Price Target on Cardinal Health to $280 From $274, Keeps Buy Rating MT
08-12 Jefferies Adjusts Price Target on Cardinal Health to $280 From $270, Maintains Buy Rating MT
08-12 Wells Fargo Adjusts Cardinal Health Price Target to $277 From $245, Maintains Overweight Rating MT
08-12 Citigroup Adjusts Cardinal Health Price Target to $280 From $265, Maintains Buy Rating MT
08-12 Leerink Partners Adjusts Cardinal Health PT to $292 From $275, Maintains Outperform Rating MT
08-12 Evercore ISI Adjusts Cardinal Health PT to $270 From $265, Maintains Outperform Rating MT
08-12 Mizuho Securities Adjusts Cardinal Health PT to $250 From $240, Maintains Outperform Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+7.29%
+7.34%
+1.15%
+6.64%
+1.08%
+10.08%
-6.85%
+15.51%
-6.66%
+4.72%
Average +4.03%
Weighted average by Cap. +4.54%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
274.29USD
Average target price
291.53USD
Spread / Average Target
+6.29%
High Price Target
330.00USD
Spread / Highest target
+20.31%
Low Price Target
260.00USD
Spread / Lowest Target
-5.21%

Analyst Consensus Detail

Analyst consensus - Cardinal Health, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Cardinal Health, Inc.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
MarketScreener Ratings - Cardinal Health, Inc.
  1. Stock Market
  2. Stocks
  3. CAH Stock
  4. Consensus Cardinal Health, Inc.